Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (23)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Changes in the Objective Structured Clinical Examination (OSCE) of University Schools of Medicine during COVID-19. Experience with a computer-based case simulation OSCE (CCS-OSCE)

    Revista Clinica Espanola, Vol. 221, Núm. 8, pp. 456-463

2020

  1. iPSC-Derived Intestinal Organoids from Cystic Fibrosis Patients Acquire CFTR Activity upon TALEN-Mediated Repair of the p.F508del Mutation

    Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 858-870

2019

  1. Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 18, pp. 101-111

2018

  1. Learning to detect deception from evasive answers and inconsistencies across repeated interviews: A study with lay respondents and police officers

    Frontiers in Psychology, Vol. 8, Núm. JAN

2016

  1. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients

    Journal of Cystic Fibrosis, Vol. 15, Núm. 5, pp. 611-618

  2. Myopodin methylation is a prognostic biomarker and predicts antiangiogenic response in advanced kidney cancer

    Tumor Biology, Vol. 37, Núm. 10, pp. 14301-14310

  3. Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis

    International Journal of Pharmaceutics, Vol. 498, Núm. 1-2, pp. 263-273

  4. Stability study of sodium colistimethate-loaded lipid nanoparticles

    Journal of Microencapsulation, Vol. 33, Núm. 7, pp. 636-645

2014

  1. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis

    International Journal of Pharmaceutics, Vol. 477, Núm. 1-2, pp. 485-494

2013

  1. Asociación entre la exposición a paracetamol y el asma: estado de la cuestión y recomendaciones prácticas

    Anales de Pediatria, Vol. 79, Núm. 3

2010

  1. Analysis of the economic impact of cystic echinococcosis in Spain

    Bulletin of the World Health Organization, Vol. 88, Núm. 1, pp. 49-57

2008

  1. Echinococcus granulosus infection in Spain

    Zoonoses and Public Health, Vol. 55, Núm. 3, pp. 156-165

2007

  1. Avances recientes en el inmunodiagnóstico de la hidatidosis humana

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 4, pp. 263-269

  2. The immunodiagnosis of Echinococcus multilocularis infection

    Clinical Microbiology and Infection, Vol. 13, Núm. 5, pp. 460-475

2006

  1. Antigens for the immunodiagnosis of Echinococcus granulosus infection: An update

    Acta Tropica, Vol. 98, Núm. 1, pp. 74-86

  2. Dog echinococcosis in northern Spain: Comparison of coproantigen and serum antibody assays with coprological exam

    Veterinary Parasitology, Vol. 142, Núm. 1-2, pp. 102-111

2005

  1. Double-antibody sandwich ELISA using biotinylated antibodies for the detection of Echinococcus granulosus coproantigens in dogs

    Acta Tropica, Vol. 95, Núm. 1, pp. 9-15